The article focuses on Novodiag® solution, the automated molecular diagnostic system allowing rapid and reliable results directly from patient sample.
Our CEO Tuomas Tenkanen explains Mobidiag’s positioning and its dedication to the fight against antibiotic resistances.
See Finnish version (original version).
